top of page

SYNHALE THERAPEUTICS

Revolutionizing Pulmonary Hypertension Treatment

Media & Press

Synhale Therapeutics AcquiresTelaglenastat,
Accelerates Development for Pulmonary Hypertension Treatment 

Synhale Therapeutics Inc.

May 1, 2025

Read Article
bottom of page